|
Who Writes This Diabetes Stuff Anyway
Look Here
See Harlan's Other Health Web Sites
Look Here
The story on the new
study says that they analyzed more than 84,000 type 2 diabetes patients
in a study in Canada, comparing effects of the thiazolidinediones with
the category, known as sulfonylureas.
Those results reported to show that thiazolidinedione use increased the
risk of peripheral fractures by 28 percent.
In contrast Actos was associated with a 77 percent rise in fractures in
women, which was considerably lower (17 percent) with Avandia.
"Our findings suggest that both men and women are at increased risk
of fracture as a result of exposure to thiazolidinediones and that
pioglitazone treatment may be more strongly associated with fractures
than rosiglitazone treatment," the study's authors wrote.
Editors Note;
This shows that "the use of some Diabetes drugs could weaken
bones more than acceptable (if patients were told) and that other
alternatives that do not weaken bones should be considered.
Home Page
Contact Us
Privacy Policy
Top of Page
|
